Heparin, platelets and blood coagulation: implications for low-dose heparin prophylactic regimens in venous thrombosis.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000991:Antithrombins / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D001779:Blood Coagulation Factors; D001792:Blood Platelets / Q000187:drug effects*; D002118:Calcium / Q000494:pharmacology; D002951:Citrates; D005170:Factor X; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007279:Injections, Subcutaneous; D008722:Methods; D010973:Platelet Adhesiveness / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D013696:Temperature; D013917:Thrombin / Q000494:pharmacology; D013924:Thrombophlebitis / Q000517:prevention & control*; D013997:Time Factors; D014316:Tritium
D000991:Antithrombins; D001779:Blood Coagulation Factors; D002951:Citrates; D014316:Tritium; D012701:Serotonin; D000244:Adenosine Diphosphate; D005170:Factor X; D006493:Heparin; D013917:Thrombin; D002118:Calcium